ArticleMediterranean journal of hematology and infectious diseases2022
Sinopharm Vaccine, SARS-CoV-2 Breakthrough Infections and Hemoglobinopathies.
Rujittika Mungmunpuntipantip et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it